Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE MKT LLC:BTX)

3.67
Delayed Data
As of 4:00pm ET
 -0.13 / -3.42%
Today’s Change
2.02
Today|||52-Week Range
4.16
-2.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$392.9M

Company Description

BioTime, Inc. engages in biotechnology business. It focuses on research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer, and hydrogel products that may be used in surgery, and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Alameda, CA.

Contact Information

BioTime, Inc.
1010 Atlantic Avenue
Alameda California 94501-7850
P:(510) 521-3390
Investor Relations:
(510) 775-0510

Employees

Shareholders

Mutual fund holders6.76%
Individual stakeholders39.37%
Other institutional38.96%

Top Executives

Michael D. WestCo-President, Co-CEO & Director
Aditya P. MohantyCo-President, Co-CEO & Director
Russell L. SkibstedCFO & Principal Accounting Officer
Hal SternbergVice President-Research
Judith SegallSecretary, Director & VP-Administration